Indivior PLC
LSE:INDV
Indivior PLC
Cash from Investing Activities
Indivior PLC
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Indivior PLC
LSE:INDV
|
Cash from Investing Activities
$54m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash from Investing Activities
-£1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
AstraZeneca PLC
LSE:AZN
|
Cash from Investing Activities
-$5.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Cash from Investing Activities
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash from Investing Activities
-$333m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-11%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Cash from Investing Activities
-£426.2m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-36%
|
See Also
What is Indivior PLC's Cash from Investing Activities?
Cash from Investing Activities
54m
USD
Based on the financial report for Mar 31, 2024, Indivior PLC's Cash from Investing Activities amounts to 54m USD.